Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Medicamentos para prevenir el paludismo (malaria) al viajar - Chloroquina (Aralen™)
  • Published Date:
    6/27/14
  • Language:
    Spanish
Filetype[PDF-422.66 KB]


Details:
  • Alternative Title:
    Medicines for the prevention of malaria while traveling - Chloroquine [Spanish]
  • Corporate Authors:
    Center for Global Health (U.S.). Division of Parasitic Diseases and Malaria.
  • Description:
    Medicines for the prevention of malaria while traveling - Chloroquine [Spanish] A cloroquina (também conhecida como fosfato de cloroquina) é um medicamento antimalária. Ela está disponível nos Estados Unidos para venda com prescrição médica. Ela é vendida sob o nome comercial Aralen e também é vendida como medicamento genérico. Ela está disponível em comprimidos de dois tamanhos: 150 mg de base (250 mg de sal) e 300 mg de base (500 mg de sal). Você precisa estar ciente de que o comprimido contendo 150 mg de base é o mesmo que o comprimido contendo 250mg de sal e que o comprimido contendo 300 mg de base é o mesmo que o comprimido contendo 500 mg de sal. Trata-se apenas de duas maneiras diferentes de descrever a mesma coisa. A cloroquina pode ser prescrita seja para prevenção, seja para o tratamento da malária. Este folheto informativo oferece informações sobre o seu uso na prevenção da infecção por malária associada a viagens. CS237187-A
  • Subject:
  • Document Type:
    Pamphlet (or booklet)
  • Collection(s):
    Stephen B. Thacker CDC Library collection
  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Federal government adjusts COVID-19 entry strategy for international air passengers : media statement : for immediate release: Wednesday, September 9, 2020
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    September 9, 2020
    Description:
    As the COVID-19 pandemic continues, the United States Government (USG) is innovating and taking a new approach to help keep international air passengers healthy. The new, more effective strategy focuses on the continuum of travel and the individual p...
    File Type:
    Filetype[PDF - 70.18 KB]
  2. Delay your travel to avoid spreading COVID-19 if you are sick with a fever, cough or other symptoms of COVID-19
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    09/09/2020
    Description:
    Updated Sept. 11, 2020People who are sick, have recently tested positive for the virus that causes COVID-19, or have been exposed to a person with COVID-19 pose a risk to others during travel. This page gives advice on when and how long people should...
    File Type:
    Filetype[PDF - 408.65 KB]
  3. Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment — United States, January–June 2020
    Personal Author:
    Bull-Otterson, Lara; Gray, Elizabeth B.; Budnitz, Daniel S.; Strosnider, Heather M.; Schieber, Lyna Z.; Courtney, Joseph; García, Macarena C.; Brooks, John T.; Mac Kenzie, William R.; Gundlapalli, Adi V.;
    Published Date:
    September 04 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(35):1210-1215
    Description:
    Hydroxychloroquine and chloroquine, primarily used to treat autoimmune diseases and to prevent and treat malaria, received national attention in early March 2020, as potential treatment and prophylaxis for coronavirus disease 2019 (COVID-19) (1). On ...
    File Type:
    Filetype[PDF - 155.90 KB]
  4. Enhanced contact investigations for nine early travel-related cases of SARS-CoV-2 in the United States
    Personal Author:
    Burke, Rachel M.; Balter, Sharon; Barnes, Emily; Barry, Vaughn; Bartlett, Karri; Beer, Karlyn D.; Benowitz, Isaac; Biggs, Holly M.; Bruce, Hollianne; Bryant-Genevier, Jonathan; Cates, Jordan; Chatham-Stephens, Kevin; Chea, Nora; Chiou, Howard; Christiansen, Demian; Chu, Victoria T.; Clark, Shauna; Cody, Sara H.; Cohen, Max; Conners, Erin E.; Dasari, Vishal; Dawson, Patrick; DeSalvo, Traci; Donahue, Matthew; Dratch, Alissa; Duca, Lindsey; Duchin, Jeffrey; Dyal, Jonathan W.; Feldstein, Leora R.; Fenstersheib, Marty; Fischer, Marc; Fisher, Rebecca; Foo, Chelsea; Freeman-Ponder, Brandi; Fry, Alicia M.; Gant, Jessica; Gautom, Romesh; Ghinai, Isaac; Gounder, Prabhu; Grigg, Cheri T.; Gunzenhauser, Jeffrey; Hall, Aron J.; Han, George S.; Haupt, Thomas; Holshue, Michelle; Hunter, Jennifer; Ibrahim, Mireille B.; Jacobs, Max W.; Jarashow, M. Claire; Joshi, Kiran; Kamali, Talar; Kawakami, Vance; Kim, Moon; Kirking, Hannah L.; Kita-Yarbro, Amanda; Klos, Rachel; Kobayashi, Miwako; Kocharian, Anna; Lang, Misty; Layden, Jennifer; Leidman, Eva; Lindquist, Scott; Lindstrom, Stephen; Link-Gelles, Ruth; Marlow, Mariel; Mattison, Claire P.; McClung, Nancy; McPherson, Tristan D.; Mello, Lynn; Midgley, Claire M.; Novosad, Shannon; Patel, Megan T.; Pettrone, Kristen; Pillai, Satish K.; Pray, Ian W.; Reese, Heather E.; Rhodes, Heather; Robinson, Susan; Rolfes, Melissa; Routh, Janell; Rubin, Rachel; Rudman, Sarah L.; Russell, Denny; Scott, Sarah; Shetty, Varun; Smith-Jeffcoat, Sarah E.; Soda, Elizabeth A.; Spitters, Christopher; Stierman, Bryan; Sunenshine, Rebecca; Terashita, Dawn; Traub, Elizabeth; Vahey, Grace M.; Verani, Jennifer R.; Wallace, Megan; Westercamp, Matthew; Wortham, Jonathan; Xie, Amy; Yousaf, Anna; Zahn, Matthew;
    Published Date:
    September 02 2020
    Source:
    PLoS One. 15(9)
    Description:
    Coronavirus disease 2019 (COVID-19), the respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, China and has since become pandemic. In response to the first cases identified in the ...
    File Type:
    Filetype[PDF - 842.01 KB]
  5. Crew disembarkations through commercial travel
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    August 11, 2020
    Description:
    Updated Aug. 11, 2020CDC is committed to helping cruise lines provide for the safety and well-being of their crew members while onboard cruise ships and as they disembark. CDC is allowing crew members to disembark from all cruise ships in U.S. waters...
    File Type:
    Filetype[PDF - 206.13 KB]